什么是 SEC Form 13F 申报?美股机构大户持股全攻略
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制,学会如何追踪顶级对冲基金与机构法人持仓动向。
CIK: 0001858703
申报总市值
US$6.6亿
US$6.6亿
75 檔
26.0%
截至 Q1 2026 季度末,Blue Owl Capital Holdings LP 的美股持仓估值约为 US$6.6亿,全数申报仓位共有 75 档。
Blue Owl Capital Holdings LP 在 Q1 2026 进行了结构性的板块轮动与仓位换股。在开立 20 个全新仓位及加仓 12 档持股的同时,亦同步清仓 25 档并减仓 16 档标的。
在资产配置集中度方面,Blue Owl Capital Holdings LP 的前 5 大核心持股(包含 AKTS, LRMR, ENGENE HOLDINGS INC 等)合计占整体申报市值的 26.0%,反映机构在主要关键仓位上的权重分布。
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | AKTS | Aktis Oncology Inc | 股票-其他 | 15.20% | -0.31% | — | |
| 2 | LRMR | Larimar Therapeutics Inc | 股票-其他 | 8.61% | -4.40% | +4.34% | |
| 3 | ✓ | Engene Holdings Inc | 股票-其他 | 8.08% | -8.08% | EXIT | |
| 4 | NCDL | Nuveen Churchill Direct Lend | 股票-其他 | 7.33% | -3.32% | — | |
| 5 | CGEM | Cullinan Therapeutics Inc | 股票-其他 | 7.29% | -3.07% | -18.77% | |
| 6 | OBDC | Blue Owl Capital CORP | 股票-金融 | 6.08% | -2.73% | — | |
| 7 | MPLT | Maplight Therapeutics Inc | 股票-其他 | 5.49% | -1.55% | +207.57% | |
| 8 | CMPX | Compass Therapeutics Inc | 股票-其他 | 4.18% | -2.99% | -15.14% | |
| 9 | CNTX | Context Therapeutics Inc | 股票-其他 | 3.58% | -3.34% | -31.53% | |
| 10 | HLLY | Holley Inc | 股票-其他 | 3.49% | -1.81% | +2.18% | |
| 11 | EYPT | Eyepoint Inc | 股票-其他 | 3.16% | -1.52% | +132.45% | |
| 12 | CRVS | Corvus Pharmaceuticals Inc | 股票-其他 | 2.14% | -0.77% | — | |
| 13 | CNDT | Conduent Inc | 股票-其他 | 1.73% | -0.62% | +4.44% | |
| 14 | RARE | Ultragenyx Pharmaceutical In | 股票-其他 | 1.70% | -0.78% | +42.33% | |
| 15 | AQST | Aquestive Therapeutics Inc | 股票-其他 | 1.50% | -0.91% | +156.75% | |
| 16 | RYTM | Rhythm Pharmaceuticals Inc | 股票-其他 | 1.44% | -0.41% | — | |
| 17 | ✓ | Compass Pathways PLC | 股票-其他 | 1.38% | -0.60% | — | |
| 18 | IMMX | Immix Biopharma Inc | 股票-其他 | 1.34% | -0.66% | -44.48% | |
| 19 | IMA | Imagenebio Inc | 股票-其他 | 1.29% | -0.48% | +16.45% | |
| 20 | CVEO | Civeo CORP | 股票-其他 | 1.28% | -1.28% | EXIT | |
| 21 | LENZ | Lenz Therapeutics Inc | 股票-其他 | 1.25% | -0.60% | +237.81% | |
| 22 | ELDN | Eledon Pharmaceuticals Inc | 股票-其他 | 1.18% | -0.84% | -26.43% | |
| 23 | 4XC1 | Kalvista Pharmaceuticals Inc | 股票-其他 | 1.16% | -1.16% | EXIT | |
| 24 | OVID | Ovid Therapeutics Inc | 股票-其他 | 1.14% | -1.14% | EXIT | |
| 25 | PVLA | Palvella Therapeutics Inc | 股票-其他 | 1.05% | -0.22% | -22.36% | |
| 26 | PLRX | Pliant Therapeutics Inc | 股票-其他 | 1.01% | -1.01% | EXIT | |
| 27 | STWD | Starwood Property Trust Inc | 股票-房地产 | 0.73% | -0.25% | — | |
| 28 | ✓ | Adc Therapeutics SA | 股票-其他 | 0.70% | -0.58% | — | |
| 29 | EVMN | Evommune Inc | 股票-其他 | 0.62% | -0.26% | — | |
| 30 | DELL | Dell Technologies -c | 股票-科技 | 0.61% | +1.53% | -74.19% | |
| 31 | ✓ | Larimar Therapeutics Inc | 股票-其他 | 0.51% | -0.49% | — | |
| 32 | ORIC | Oric Pharmaceuticals Inc | 股票-其他 | 0.51% | +0.14% | -70.87% | |
| 33 | SGMT | Sagimet Biosciences Inc-a | 股票-其他 | 0.47% | +1.00% | -73.16% | |
| 34 | WW | Ww International Inc-new | 股票-其他 | 0.35% | -0.15% | — | |
| 35 | ✓ | Engene Holdings Inc | 股票-其他 | 0.35% | -0.35% | EXIT | |
| 36 | EPD | Enterprise Products Partners | 股票-能源 | 0.32% | -0.32% | EXIT | |
| 37 | FLD | Fold Holdings Inc | 股票-其他 | 0.30% | -0.24% | — | |
| 38 | OPTXW | Omnilit Acquisition Cl A -23 | 股票-其他 | 0.23% | -0.23% | EXIT | |
| 39 | MRKR | Marker Therapeutics Inc | 股票-其他 | 0.19% | -0.07% | — | |
| 40 | ✓ | Mineralys Therapeutics Inc | 股票-其他 | 0.16% | -0.16% | EXIT | |
| 41 | NIOBW | Niocorp Developments LTD -28 | 股票-其他 | 0.14% | -0.08% | -63.47% | |
| 42 | ✓ | Compass Therapeutics Inc | 股票-其他 | 0.13% | -0.11% | — | |
| 43 | BNAIW | Brand Engagement Netwo -cw27 | 股票-其他 | 0.11% | -0.08% | -38.86% | |
| 44 | CAH | Cardinal Health Inc | 股票-医疗保健 | 0.10% | -0.10% | EXIT | |
| 45 | ✓ | Rezolve Ai LTD | 股票-其他 | 0.05% | -0.02% | -18.73% | |
| 46 | PIPR | Piper Sandler Cos | 股票-金融 | 0.05% | -0.02% | — | |
| 47 | ✓ | Alpha Modus Hldgs Inc | 股票-其他 | 0.04% | -0.04% | EXIT | |
| 48 | ET | Energy Transfer LP | 股票-能源 | 0.03% | -0.01% | — | |
| 49 | ✓ | 股票-其他 | 0.03% | -0.03% | EXIT | ||
| 50 | CAI | Caris Life Sciences Inc | 股票-其他 | 0.02% | -0.01% | — |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | MPLT | Maplight Therapeutics Inc | +3.7% | +207.57% | 加仓 |
| 2 | EYPT | Eyepoint Inc | +1% | +132.45% | 加仓 |
| 3 | LRMR | Larimar Therapeutics Inc | +0.6% | +4.34% | 加仓 |
| 4 | LENZ | Lenz Therapeutics Inc | +0.5% | +237.81% | 加仓 |
| 5 | AQST | Aquestive Therapeutics Inc | +0.5% | +156.75% | 加仓 |
| 6 | ✓ | Engene Holdings Inc | +0.3% | +1316.00% | 加仓 |
| 7 | ELDN | Eledon Pharmaceuticals Inc | +0.3% | -26.43% | 减仓 |
| 8 | CNTX | Context Therapeutics Inc | +0.2% | -31.53% | 减仓 |
| 9 | RARE | Ultragenyx Pharmaceutical In | +0.2% | +42.33% | 加仓 |
| 10 | OPTXW | Omnilit Acquisition Cl A -23 | +0.2% | — | 不变 |
| 11 | BNAIW | Brand Engagement Netwo -cw27 | +0.1% | -38.86% | 减仓 |
| 12 | EPD | Enterprise Products Partners | 0% | — | 不变 |
| 13 | FLD | Fold Holdings Inc | — | — | 不变 |
| 14 | SHFS | Shf Holdings Inc | — | — | 不变 |
| 15 | ✓ | Pagaya Technologies LTD | — | — | 不变 |
| 16 | AEON | Aeon Biopharma Inc | — | -2.40% | 减仓 |
| 17 | BTMWQ | Bitcoin Depot Inc-cw23 | — | — | 不变 |
| 18 | ✓ | — | — | 不变 | |
| 19 | TVGNW | Semper Paratus Acqu -cw26 | — | — | 不变 |
| 20 | XBPEW | Cf Acquisition Viii A -cw27 | — | — | 不变 |
| 21 | SDSTW | Global Partner Acq A -cw27 | — | -47.37% | 减仓 |
| 22 | LIMNW | Liminatus Pharma Inc-cl A-28 | — | — | 不变 |
| 23 | ASBPW | Aspire Biopharma Holdin-cw27 | — | — | 不变 |
| 24 | ✓ | Katapult Holdings Inc | — | — | 不变 |
| 25 | ✓ | Waldencast PLC | — | — | 不变 |
| 26 | SLND-WS | Legato Merger CORP Ii -cw23 | 0% | — | 不变 |
| 27 | ✓ | Blue Gold LTD | 0% | — | 不变 |
| 28 | ✓ | Roadzen Inc | 0% | — | 不变 |
| 29 | DAVEW | Dave Inc -cw27 | 0% | — | 不变 |
| 30 | AMODW | Insight Acquisition Co -cw23 | 0% | — | 不变 |
| 31 | DAICW | Cid Holdco Inc -26 | 0% | +48.17% | 加仓 |
| 32 | CAH | Cardinal Health Inc | 0% | — | 不变 |
| 33 | BKSY-WS | Blacksky Technology -cw24 | 0% | — | 不变 |
| 34 | ✓ | Rezolve Ai LTD | 0% | -18.73% | 减仓 |
| 35 | ✓ | Alpha Modus Hldgs Inc | 0% | — | 不变 |
| 36 | ✓ | -0.1% | — | 不变 | |
| 37 | MRKR | Marker Therapeutics Inc | -0.1% | — | 不变 |
| 38 | PLRX | Pliant Therapeutics Inc | -0.1% | — | 不变 |
| 39 | ✓ | Adc Therapeutics SA | -0.2% | — | 不变 |
| 40 | CGEM | Cullinan Therapeutics Inc | -0.2% | -18.77% | 减仓 |
| 41 | PVLA | Palvella Therapeutics Inc | -0.3% | -22.36% | 减仓 |
| 42 | IMMX | Immix Biopharma Inc | -0.3% | -44.48% | 减仓 |
| 43 | NIOBW | Niocorp Developments LTD -28 | -0.4% | -63.47% | 减仓 |
| 44 | IMA | Imagenebio Inc | -0.5% | +16.45% | 加仓 |
| 45 | 4XC1 | Kalvista Pharmaceuticals Inc | -0.6% | -40.28% | 减仓 |
| 46 | ORIC | Oric Pharmaceuticals Inc | -0.8% | -70.87% | 减仓 |
| 47 | CNDT | Conduent Inc | -1.1% | +4.44% | 加仓 |
| 48 | ✓ | Engene Holdings Inc | -1.3% | +31.40% | 加仓 |
| 49 | CVEO | Civeo CORP | -1.3% | -51.29% | 减仓 |
| 50 | DELL | Dell Technologies -c | -1.5% | -74.19% | 减仓 |
根据 SEC 官方 Form 13F 申报备案,Blue Owl Capital Holdings LP 在 Q1 2026 季度的美股持仓总市值约为 US$6.6亿,共申报了 75 个公开持股仓位。
在 Q1 2026 季度,Blue Owl Capital Holdings LP 按市值排列的前三大核心持股分别为:AKTS (15.2%)、LRMR (8.6%)、ENGENE HOLDINGS INC (8.1%)。其中最大持股仓位 AKTS 占据整体投资组合约 15.2% 的权重。
精选 AlphaSMO 大户持股与内部人交易深度分析,提升投资决策胜率
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制,学会如何追踪顶级对冲基金与机构法人持仓动向。
本季最大新建仓标的
AKTS
市值: US$5655.7万
本季最大获利了结 / 清仓标的
RPTX
前期市值: US$895.4万
在 Q1 2026 季度中,Blue Owl Capital Holdings LP 共进行了 73 项持仓异动,包含新建仓 20 个仓位、加仓 12 个仓位、减仓 16 个仓位以及清仓 25 个仓位。 其中最大新建仓标的为 AKTS。 本季清仓仓位包含 RPTX。
本页面所有持股数据均直接同步自美国证券交易委员会(SEC)EDGAR 官方系统之 13F-HR / 13F-HR/A 季度申报文件。AlphaSMO 通过机器解析 CUSIP 与个股对照,提供 100% 精准对齐的历史时序数据集,并支持 Schema.org 结构化数据格式。
解析公司高管、董事与 10% 大股东之 Form 4 内部人交易申报,掌握高管自家股票买卖第一手信号。
深入剖析 5% 股权申报门槛、13D 与 13G 之差异,以及最新 SEC 申报时程规范,洞察机构法人的激进投资动向。